Dr. Christopher William Kinter is a Miami, Florida based male rheumatologist who is specialized in Rheumatology. Active license number of Dr. Christopher William Kinter for Rheumatology is ME167547 in Florida. Dr. Christopher William Kinter treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Christopher William Kinter speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Male
Practice Address:
20880 W Dixie Hwy Ste 101, Miami, Florida, 33180-1151
Phone:
305-682-1441
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1245799436
NPI Enumeration Date:
18 Mar, 2019
NPI Last Update On:
02 Jul, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Christopher William Kinter are as mentioned below.
License Number
Specialization
State
Status
ME167547
Rheumatologist
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
20880 W Dixie Hwy Ste 101, Miami, Florida
Zip:
33180-1151
Phone Number:
305-682-1441
Fax Number:
--
Patients can reach Dr. Christopher William Kinter at 20880 W Dixie Hwy Ste 101, Miami, Florida or can call to book an appointment on 305-682-1441. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.